JFR 2013 again to include 'interventional village'
July 24, 2013 -- The Journées Françaises de Radiologie (JFR) 2013 meeting to be held in Paris this autumn will once again include an "interventional village" -- a large exhibition room dedicated to interventional courses and demonstrations, according to JFR.
Echocardiography not indicated for asymptomatic screening
July 22, 2013 -- Echocardiography screening for structural and valvular heart disease does not lead to reduced risk of death, myocardial infarction, or stroke, according to a long-term Norwegian study published online July 22 in JAMA Internal Medicine.
Philips promotes new x-ray dose study at EuroPCR
May 21, 2013 -- Royal Philips Electronics, parent company of Philips Healthcare, in a joint study with the Radboud University Nijmegen Medical Centre in the Netherlands and Main-Taunus Cardiac Center in Germany, has announced that a 50% reduction in x-ray dose may be achieved in image-guided cardiac interventions using the AlluraClarity angiography system with ClarityIQ technology.
Philips adds 2D intracardiac echo support
May 21, 2013 -- Philips Healthcare has added 2D intracardiac echocardiography capability to its CX50 xMatrix portable ultrasound system, thanks to a partnership with cardiac technology developer St. Jude Medical.
Hybrid imaging set to drive interventional market
May 8, 2013 -- The European market for interventional radiology and cardiology is heading toward maturity, but expanding applications and hybrid operating rooms are expected to power market growth from 2013 to 2017, according to a new report from market research firm Frost & Sullivan.
Salsa, lifestyle, and diet contribute to drop in disease
April 10, 2013 -- Modest population-wide weight loss could result in dramatic reductions in the burden of type 2 diabetes and cardiovascular disease, according to a new study published online on 9 April in the British Medical Journal.
GE asks for EU manufacturing permission for Optison
March 29, 2013 -- GE Healthcare said it has applied to the European Medicines Agency to amend its marketing authorization to allow the company to manufacture its Optison echocardiography contrast agent at its own facility in Norway.
ESC applauds EC medical device regulation proposals
March 8, 2013 -- The European Society of Cardiology (ESC) said that the European Commission's proposal for a new regulation to govern the evaluation and approval of medical devices in Europe is an important step toward improving patient safety.